+15075562445 (US)
sales@htfmarketintelligence.com
Published: Nov 03, 2025
ID: 4394414
123 Pages
Cryogenic Storage
for Biologics

Cryogenic Storage for Biologics Industry Sets New Growth Stage

Global Cryogenic Storage for Biologics Market is segmented by Application (Biotechnology, Pharmaceuticals, Vaccine Storage, Medical Research, Healthcare), Type (Cryogenic Freezers, Cryogenic Tanks, Cryogenic Transport Systems, Cryopreservation Systems, Liquid Nitrogen Systems), and Geography (North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

Report ID:
HTF4394414
Published:
CAGR:
17.90%
Market Size (2024):
$6.5 billion
Forecast (2033):
$13.3 billion

Pricing

Report Overview

Industry Overview


The Cryogenic Storage for Biologics is at 6.5 billion in 2024 and is expected to reach 13.3 billion by 2033. The Cryogenic Storage for Biologics is driven by factors such as increasing demand in end-use industries, technological advancements, research and development (R&D), economic growth, and increasing global trade. Thermo Fisher Scientific (US), Cryoport (US), Stirling Ultracold (US), Haier Biomedical (China), Panasonic Healthcare (Japan), Biologistex (US), KHS GmbH (Germany), B Medical Systems (Luxembourg), Danaher Corporation (US), Helmer Scientific (US), Labconco (US), BioLife Solutions (US), KRYO (US), Taylor-Wharton (US), MVE Biological Solutions (US) and others are some of the key players in the market.

Cryogenic storage for biologics involves the use of low-temperature systems to preserve biological samples, vaccines, and biologic drugs. These solutions are crucial in the pharmaceutical and biotechnology industries, where temperature stability is essential to maintain the efficacy of sensitive materials. The market is growing due to the increasing demand for biologics and vaccines, particularly in the context of global healthcare challenges.

Cryogenic Storage for Biologics Market Compound Annual Growth Rate 2024-2033

Source: HTF Market Intelligence (HTF MI)

Key Players


Several key players in the Cryogenic Storage for Biologics market are strategically focusing on expanding their operations in developing regions to capture a larger market share, particularly as the year-on-year growth rate for the market stands at 15.30%. The companies featured in this profile were selected based on insights from primary experts, evaluating their market penetration, product offerings, and geographical reach. 
  • Thermo Fisher Scientific (US)
  • Cryoport (US)
  • Stirling Ultracold (US)
  • Haier Biomedical (China)
  • Panasonic Healthcare (Japan)
  • Biologistex (US)
  • KHS GmbH (Germany)
  • B Medical Systems (Luxembourg)
  • Danaher Corporation (US)
  • Helmer Scientific (US)
  • Labconco (US)
  • BioLife Solutions (US)
  • KRYO (US)
  • Taylor-Wharton (US)
  • MVE Biological Solutions (US)
Cryogenic Storage for Biologics Market share of Thermo Fisher Scientific (US), Cryoport (US), Stirling Ultracold (US), Haier Biomedical (China), Panasonic Healthcare (Japan), Biologistex (US), KHS GmbH (Germany), B Medical Systems (Luxembourg), Danaher Corporation (US), Helmer Scientific (US), Labconco (US), BioLife Solutions (US), KRYO (US), Taylor-Wharton (US), MVE Biological Solutions (US)

Cryogenic Storage for Biologics Market Dynamics Highlights


Key Highlights

  • The Cryogenic Storage for Biologics is growing at a 17.90% during the forecasted period of 2020 to 2033
  • Based on type, the market is bifurcated into Cryogenic Freezers, Cryogenic Tanks, Cryogenic Transport Systems, Cryopreservation Systems, Liquid Nitrogen Systems
  • Based on application, the market is segmented into Biotechnology, Pharmaceuticals, Vaccine Storage, Medical Research, Healthcare
  • Global import/export in terms of K tons, K units, and metric tons will be provided if applicable based on industry best practices.

Market Segmentation Overview

  • Type Segmentation: categorizes products by their specific variants, helping businesses identify demand drivers and innovate effectively.
  • Application Segmentation: Divides the market based on product usage across industries, enabling targeted marketing and growth identification.
  • Geographic Segmentation: Segments the market by location, allowing for tailored strategies based on regional preferences and economic factors.
  • Customer Segmentation: Focuses on demographics like age, gender, and income, enabling personalized marketing and improved customer targeting.
  • Distribution Channel Segmentation: categorizes how products reach customers, optimizing supply chain and sales strategies.

Market Segmentation


Segmentation by Type
  • Cryogenic Freezers
  • Cryogenic Tanks
  • Cryogenic Transport Systems
  • Cryopreservation Systems
  • Liquid Nitrogen Systems
Segmentation by Application
 
  • Biotechnology
  • Pharmaceuticals
  • Vaccine Storage
  • Medical Research
  • Healthcare
 
Cryogenic Storage for Biologics Market segment share by Biotechnology, Pharmaceuticals, Vaccine Storage, Medical Research, Healthcare

Understand Key Market Dynamics

Need More Details on Market Players and Competitors?

Regional Analysis

  • North America
  • LATAM
  • West Europe
  • Central & Eastern Europe
  • Northern Europe
  • Southern Europe
  • East Asia
  • Southeast Asia
  • South Asia
  • Central Asia
  • Oceania
  • MEA


Loading map...

Market Entropy


Merger & Acquisition


Regulatory Landscape


Patent Analysis


Investment and Funding Scenario


Competitive Innovation Radar

Cryogenic Storage for Biologics Market trend and sizing by Cryogenic Freezers, Cryogenic Tanks, Cryogenic Transport Systems, Cryopreservation Systems, Liquid Nitrogen Systems


Market Driver

  • Increasing Demand For Biologic Drugs
  • Need For Long-Term Storage Of Vaccines
  • Rising Investments In Biotech Research
  • Growing Adoption Of Cryopreservation
  • Need For Stable Storage Solutions
Market Trends
  • Focus On Energy-Efficient Cryogenic Systems
  • Rise In Biopharmaceutical Storage
  • Growth In Biotech and Vaccine Research
  • Increased Adoption Of Temperature Monitoring Systems
  • Use Of Cryogenics For Personalized Medicine
Opportunity
  • Expansion In Biotech and Vaccine Research
  • Growth In Cryogenic Transport Solutions
  • Increased Demand For Stable Biologic Drug Storage
  • Use Of Cryogenic Systems In Personalized Medicine
  • Focus On Energy-Efficient Cryogenic Solutions
Challenges
  • High Costs Of Cryogenic Systems
  • Limited Availability Of Cryogenic Infrastructure
  • Regulatory Compliance Issues
  • Equipment Maintenance Costs
  • Risk Of Sample Loss

Primary & Secondary Approach


The Cryogenic Storage for Biologics is analyzed by both primary and secondary research sources. There are numerous methodologies available to navigate and utilize these resources effectively:
Surveys and Questionnaires: Getting feedback from healthcare professionals, patients, or any other stakeholders on a particular topic. It is a great method to collect quantitative data on behaviors, preferences, and/or experiences.
One-on-ones: Interviews with key stakeholders, including physicians, nurses, and administrators, can yield rich qualitative data. The interviews can be divided into structured, semi-structured, or unstructured.


Focus Groups: Pull together small numbers of people who share a common characteristic, trait, or behavior to discuss particular topics. Focus Groups: This offers qualitative data and points of view that are often overlooked, such as attitudes, perceptions, or other statements relating to a specific platform.


Observational Studies: Understanding healthcare practices and patient interactions in the way we do it can say a lot more than what people formally report doing.
Field Studies: This method allows researchers to collect data firsthand from healthcare settings, including hospitals, clinics, and even homes. It is a way to touch and feel the context that drives service delivery in healthcare.
Secondary Research in Cryogenic Storage for Biologics
Secondary research is a kind of revising, restructuring, and rethinking what has already been collected by primary sources. Such research is beneficial as long as it comes at a low cost and gives an overarching view of the market. Some of the important methods include:
Literature Review: To go through the research papers, articles, and studies published in medical journals, industry reports, and academic publications. This is crucial for understanding the study landscape and identifying knowledge deficits.
Reports From the Industry: It aims at examining reports published by market research firms, healthcare associations, and government bodies. This report can also be used by all stakeholders, including service providers and delivery chains across the world, to identify market opportunities in an undetermined depth.


Public Health Records: Data collected by governments and public health authorities in different countries of the world from organizations with global reach, like the CDC, WHO, or national departments. These are important because they provide us with epidemiological data and numbers.
Company Reports: Read the annual reports, financial statements, and press releases of healthcare companies. It includes company performance reports, market strategies, and competitive positioning for this domain.
Online Databases: You understand the access to databases like PubMed, MEDLINE, and even Google Scholar for scientific articles and study materials. Some of these databases are treasure troves for peer-reviewed data.
Media Sources: Analyzing news articles, press releases, and media coverage related to the healthcare industry. This helps in staying updated on recent developments and emerging trends.
A blended approach of primary and secondary research methods allows researchers to collect well-rounded, solid data that informs the best decisions and strategies.


Report Infographics:

Report Features Details
Base Year 2024
Based Year Market Size (2024) 6.5 billion
Historical Period Market Size (2020) USD Million ZZ
CAGR (2024 to 2033) 17.90%
Forecast Period 2026 to 2033
Forecasted Period Market Size (2033) 13.3 billion
Scope of the Report Type, Application, Region
Quantitative Units

Revenue in USD million/billion, volume in kilotons, and CAGR from 2024 to 2033

Year-on-Year Growth 15.30%
Companies Covered Thermo Fisher Scientific (US), Cryoport (US), Stirling Ultracold (US), Haier Biomedical (China), Panasonic Healthcare (Japan), Biologistex (US), KHS GmbH (Germany), B Medical Systems (Luxembourg), Danaher Corporation (US), Helmer Scientific (US), Labconco (US), BioLife Solutions (US), KRYO (US), Taylor-Wharton (US), MVE Biological Solutions (US)
Customization Scope 15% Free Customization (For EG). Customized purchase options are available to match your specific research requirements
Delivery Format PDF and Excel through Email